Decreased miR-24 sensitizes cells to apoptotic stimuli, and increases pro-apoptotic protein expression. by Tan Nguyen (278146)

“…Infected cells were selected in puromycin and decreased expression of miR-24 validated by quantitative RT-PCR (<b><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0055406#pone.0055406.s004" target="_blank">Fig S4</a></b>). …”

GroEL1 decreases integrin and E-selectin expression and induces adhesion molecule production in EPCs. by Yi-Wen Lin (143406)

BRAF and MEK inhibitor combination decreases rat skin lesion formation and increases tumor growth inhibition. by Alastair J. King (430098)

SSPEV-L and SSPEV-P proteins decrease RdRp activity. by Kento Sakamoto (16679735)

Effect of freeze-thaw cycling on grain size of biochar - Fig 10 by Zuolin Liu (633898)

STIM1 knockdown decreases Ca2+ influx, HMGB1-induced permeability and Src phosphorylation. by Mengchen Zou (725646)

Chlorogenic acid (CGA) metabolites-containing serum from CGA-treated normal mice decreases lipid accumulation and stimulates cholesterol efflux from RAW264.7 cells. by Chongming Wu (169161)

Combined therapeutic treatment with 2ME2 and SD-208 additively decreases bone metastases in mice. by Lauren K. Dunn (260121)

Loss of Abl kinase function decreased endothelial barrier dysfunction <i>in</i><i>vitro</i>. by Elizabeth M. Chislock (499669)

Full-length PRR expression increases and sPRR secretion decreases in the absence of PACE4 in mouse. by Amro H. Mohammad (15081540)

Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment by AHMET ÖZTÜRK (8077292)

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”

The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol. by Pia Steensland (362091)

“…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”

<i>In vivo</i> treatment with entinostat decreases Foxp3 expression in Tregs and inhibits Tregs function. by Li Shen (110858)

“…Cells were harvested from spleens and lymph nodes. A, <i>In vivo</i> entinostat treatment decreased the expression level of Foxp3 in CD4⁺Foxp3⁺ (Treg) cells. …”

TGF-β₁ decreased soluble FBLN-1 from human ASM cells. by Ling Chen (25698)

Inhibition of VEGF and CaMKII in OS cells dramatically decreases tumor growth <i>in vivo</i>. by Paul G. Daft (720351)

Blocking ICOS but not CD28 signaling results in decreased Tfh in the maintenance phase of the SRBC immunization model. by Isharat Yusuf (354734)

Downregulation of βig-h3 decreases adhesion, invasion and migration of human osteosarcoma cells in vitro. by Yun-Shan Guo (530568)

Cellular levels of PIP2 and PIP3 were significantly decreased by Tipe2-deficient macrophages. by Ruiling Liu (507091)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)